NA AI in Bioinformatics Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143101
- Pages: 225
-
Format:
Short Description
North America AI in Bioinformatics Market, By Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors), Industry Trends and Forecast to 2029
Market Definition
Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein, and is particularly useful in comparing genes and other sequences in proteins and other sequences within an organism or between organisms, looking at the evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is.
Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of biology to specialize in. And out of the many, bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.
Market Segmentation
The AI in bioinformatics market is categorized into five notable segments such as offering, type, products and services, application, and other sectors.
On the basis of offering, the North America AI in bioinformatics market is segmented into software, services, and others
On the basis of type, the North America AI in bioinformatics market is segmented into machine learning, deep learning, and others
On the basis of products and services, the North America AI in bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services
On the basis of application, the North America AI in bioinformatics market is segmented into genomics, microarrays, system biology, text mining, chemoinformatics & drug design, proteomics, transcriptomics, DNA sequencing, metabolomics, and others
On the basis of sector, the North America AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other sectors
Market Players
Some of the major players operating in the North America AI in bioinformatics market are:
JADBio & Gnosis Data Analysis
Fios Genomics
SOPHiA GENETICS
Biomax Informatics Inc.
DNASTAR
QIAGEN
NeoGenomics Laboratories
CelbridgeScience
Eurofins Scientific
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Insilico Medicine
Dassault Systmes
iNDX.Ai
Paige AI, Inc.
SomaLogic Operating Co., Inc.
Elucidata
TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF NORTH AMERICA AI IN BIOINFORMATICS MARKET 26
1.4 LIMITATIONS 28
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 OFFERING LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET SECTOR COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PESTEL ANALYSIS 47
4.2 PORTERS FIVE FORCES 48
5 MARKET OVERVIEW 49
5.1 DRIVERS 51
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 51
5.1.2 GROWING DEMAND FOR BIOINFORMATICS 52
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 52
5.2 RESTRAINTS 53
5.2.1 HIGH COST OF INSTRUMENTATION 53
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 53
5.3 OPPORTUNITIES 54
5.3.1 RISE IN HEALTHCARE EXPENDITURE 54
5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 54
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 55
5.4 CHALLENGES 55
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 55
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 56
6 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING 57
6.1 OVERVIEW 58
6.2 SERVICES 61
6.3 SOFTWARE 61
6.4 OTHERS 62
7 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE 64
7.1 OVERVIEW 65
7.2 MACHINE LEARNING 68
7.3 DEEP LEARNING 68
7.4 OTHERS 69
8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 71
8.1 OVERVIEW 72
8.2 BIOINFORMATICS SERVICES 75
8.2.1 DATA ANALYSIS 76
8.2.2 SEQUENCING SERVICES 76
8.2.3 DATABASE MANAGEMENT 76
8.2.4 OTHERS 76
8.3 BIOINFORMATICS PLATFORMS 76
8.3.1 SEQUENCE ANALYSIS PLATFORMS 77
8.3.2 SEQUENCE ALIGNMENT PLATFORMS 77
8.3.3 STRUCTURAL ANALYSIS PLATFORMS 78
8.3.4 SEQUENCE MANIPULATION PLATFORMS 78
8.3.5 OTHERS 78
8.4 KNOWLEDGE MANAGEMENT TOOLS 78
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 79
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 79
9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION 80
9.1 OVERVIEW 81
9.2 GENOMICS 84
9.3 CHEMOINFORMATICS & DRUG DESIGN 84
9.4 PROTEOMICS 85
9.5 DNA SEQUENCING 86
9.6 SYSTEM BIOLOGY 87
9.7 TRANSCRIPTOMICS 88
9.8 TEXT MINING 89
9.9 MICROARRAYS 90
9.10 METABOLOMICS 91
9.11 OTHERS 92
10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR 93
10.1 OVERVIEW 94
10.2 MEDICAL BIOTECHNOLOGY 97
10.3 ANIMAL BIOTECHNOLOGY 97
10.4 PLANT BIOTECHNOLOGY 98
10.5 ENVIRONMENTAL BIOTECHNOLOGY 99
10.6 FORENSIC BIOTECHNOLOGY 100
10.7 OTHERS 101
11 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY REGION 102
11.1 NORTH AMERICA 103
11.1.1 U.S. 110
11.1.2 CANADA 113
11.1.3 MEXICO 116
12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 119
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 119
13 SWOT ANALYSIS 120
14 COMPANY PROFILES 121
14.1 ILLUMINA, INC. 121
14.1.1 COMPANY SNAPSHOT 121
14.1.2 REVENUE ANALYSIS 121
14.1.3 COMPANY SHARE ANALYSIS 122
14.1.4 PRODUCT PORTFOLIO 122
14.1.5 RECENT DEVELOPMENTS 122
14.2 DASSAULT SYSTEMES 123
14.2.1 COMPANY SNAPSHOT 123
14.2.2 REVENUE ANALYSIS 123
14.2.3 COMPANY SHARE ANALYSIS 124
14.2.4 PRODUCT PORTFOLIO 124
14.2.5 RECENT DEVELOPMENT 124
14.3 EUROFINS SCIENTIFIC 125
14.3.1 COMPANY SNAPSHOT 125
14.3.2 REVENUE ANALYSIS 125
14.3.3 COMPANY SHARE ANALYSIS 126
14.3.4 PRODUCT PORTFOLIO 126
14.3.5 RECENT DEVELOPMENTS 126
14.4 THERMO FISHER SCIENTIFIC INC. 127
14.4.1 COMPANY SNAPSHOT 127
14.4.2 REVENUE ANALYSIS 127
14.4.3 COMPANY SHARE ANALYSIS 128
14.4.4 PRODUCT PORTFOLIO 128
14.4.5 RECENT DEVELOPMENTS 128
14.5 QIAGEN 129
14.5.1 COMPANY SNAPSHOT 129
14.5.2 COMPANY SHARE ANALYSIS 129
14.5.3 PRODUCT PORTFOLIO 129
14.5.4 RECENT DEVELOPMENTS 129
14.6 SOPHIA GENETICS 130
14.6.1 COMPANY SNAPSHOT 130
14.6.2 PRODUCT PORTFOLIO 130
14.6.3 RECENT DEVELOPMENT 130
14.7 ARDIGEN 131
14.7.1 COMPANY SNAPSHOT 131
14.7.2 PRODUCT PORTFOLIO 131
14.7.3 RECENT DEVELOPMENTS 131
14.8 BIOMAX INFORMATICS AG 132
14.8.1 COMPANY SNAPSHOT 132
14.8.2 PRODUCT PORTFOLIO 132
14.8.3 RECENT DEVELOPMENT 132
14.9 CELBRIDGESCIENCE. 133
14.9.1 COMPANY SNAPSHOT 133
14.9.2 PRODUCT PORTFOLIO 133
14.9.3 RECENT DEVELOPMENTS 133
14.10 DNASTAR 134
14.10.1 COMPANY SNAPSHOT 134
14.10.2 PRODUCT PORTFOLIO 134
14.10.3 RECENT DEVELOPMENTS 134
14.11 ELUCIDATA 135
14.11.1 COMPANY SNAPSHOT 135
14.11.2 PRODUCT PORTFOLIO 135
14.11.3 RECENT DEVELOPMENTS 135
14.12 FIOS GENOMICS 136
14.12.1 COMPANY SNAPSHOT 136
14.12.2 PRODUCT PORTFOLIO 136
14.12.3 RECENT DEVELOPMENTS 136
14.13 INDX. AI. 137
14.13.1 COMPANY SNAPSHOT 137
14.13.2 PRODUCT PORTFOLIO 137
14.13.3 RECENT DEVELOPMENTS 137
14.14 INSILICO MEDICINE 138
14.14.1 COMPANY SNAPSHOT 138
14.14.2 PRODUCT PORTFOLIO 138
14.14.3 RECENT DEVELOPMENTS 138
14.15 JADBIO & GNOSIS DATA ANALYSIS 140
14.15.1 COMPANY SNAPSHOT 140
14.15.2 PRODUCT PORTFOLIO 140
14.15.3 RECENT DEVELOPMENTS 140
14.16 NEOGENOMICS LABORATORIES 142
14.16.1 COMPANY SNAPSHOT 142
14.16.2 REVENUE ANALYSIS 142
14.16.3 PRODUCT PORTFOLIO 143
14.16.4 RECENT DEVELOPMENTS 143
14.17 PAIGE AI, INC. 144
14.17.1 COMPANY SNAPSHOT 144
14.17.2 PRODUCT PORTFOLIO 144
14.17.3 RECENT DEVELOPMENTS 144
14.18 SOMALOGIC OPERATING CO., INC. 145
14.18.1 COMPANY SNAPSHOT 145
14.18.2 PRODUCT PORTFOLIO 145
14.18.3 RECENT DEVELOPMENTS 145
14.19 SOURCE BIOSCIENCE. 146
14.19.1 COMPANY SNAPSHOT 146
14.19.2 PRODUCT PORTFOLIO 146
14.19.3 RECENT DEVELOPMENTS 146
14.20 STRAND LIFE SCIENCES 147
14.20.1 COMPANY SNAPSHOT 147
14.20.2 PRODUCT PORTFOLIO 147
14.20.3 RECENT DEVELOPMENTS 147
15 QUESTIONNAIRE 148
16 RELATED REPORTS 151
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
